No Picture
News

Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021

SOUTH SAN FRANCISCO, Calif., April 10, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced the availability of three poster presentation… […]

No Picture
News

Immune-Onc Therapeutics Announces First Public Presentation of Data for its Myeloid Checkpoint Inhibitor, IO-202, in Solid Tumors at AACR21

PALO ALTO, Calif.–(BUSINESS WIRE)– #AACR21–Immune-Onc Therapeutics Announces First Public Presentation of Data for its Myeloid Checkpoint Inhibitor, IO-202, in Solid Tumors at AACR21 […]

No Picture
News

Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #aacr21–Freenome, a privately held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection using a routine blood draw, today announced results of an analysi… […]

No Picture
News

Tallac Therapeutics Presents New Data on Toll-like Receptor Agonist Antibody Conjugate, TAC-001, at the 2021 Virtual Annual Meeting of the American Association for Cancer Research (AACR)

BURLINGAME, Calif.–(BUSINESS WIRE)–Tallac Therapeutics, Inc., a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer, today announced the first presentation of preclinical data demonstrating po… […]

No Picture
News

The Endpoints 20 under 40, biotech’s new normal, Stéphane Bancel’s one regret, and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here. What … […]

No Picture
News

John Robinson recruits a small band of Array vets to kickstart discovery at Cogent; Syntimmune co-founder takes charge at Arch Oncology

John Robinson Biotech is a small world — and all the more so in a tight-knit community like Boulder, CO. A serendipitous reunion with Andrew Robbins, a former colleague at Array, was what sparked John Robinson’s jump to his new gig as CSO of Cogent Bio… […]

No Picture
News

AACR: Germany’s small NK cell player Affimed makes a big splash with early lymphoma data

German small-cap Affimed has long been highlighted as a potential Cinderella story, winning milestone-rich deals with Genentech and Roivant. And on Friday the biotech continued its NK cell march, presenting the first look at in-human data ahead of this… […]

No Picture
News

Covid-19 roundup: Lilly/Incyte’s Olumiant plus remdesivir combo whiffs PhIII; France recommends mixing vaccines among younger AstraZeneca recipients

Eli Lilly has won three emergency use authorizations for Covid-19 treatments, two for its antibody cocktail containing bamlanivimab and one featuring its Incyte-parntered drug Olumiant, in combination with Gilead’s remdesivir. But the US stopped distri… […]